Simplex Trading’s Vera Therapeutics VERA Stock Holding History

Simplex Trading’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$202K	Buy	4,707 +4,516	+2,364%	+$168K	﹤0.01%	4706
2026 Q1	$7.68K	Buy	+191	New	+$8.23K	﹤0.01%	7579
2025 Q1	–	Sell	-5,011	Closed	-$161K	–	9765
2024 Q4	$211K	Buy	+5,011	New	+$222K	﹤0.01%	4459
2024 Q2	–	Sell	-3,329	Closed	-$132K	–	9907
2024 Q1	$143K	Buy	+3,329	New	+$119K	﹤0.01%	5208
2023 Q3	–	Sell	-70,522	Closed	-$1.21M	–	9915
2023 Q2	$1.13M	Buy	70,522 +61,030	+643%	+$551K	﹤0.01%	2487
2023 Q1	$73K	Buy	+9,492	New	+$73.3K	﹤0.01%	5506

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Simplex Trading's VERA Position: Q2 2026 in Review

Simplex Trading increased its Vera Therapeutics (VERA) stake by 2,364% in Q2 2026, buying an estimated $168K and bringing the position to 4,707 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #4706.

Simplex Trading first reported a position in VERA in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.13M in Q2 2023. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Simplex Trading held 4,707 shares of Vera Therapeutics worth $202K as of Q2 2026.
Simplex Trading bought 4,516 Vera Therapeutics shares in Q2 2026, an estimated $168K.
Vera Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4706 holding.
Simplex Trading first reported a position in Vera Therapeutics in Q1 2023 and has held it in 6 quarters since.
Simplex Trading's Vera Therapeutics position peaked at $1.13M in Q2 2023.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.